Clinical Trial Update: Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial evaluating the safety and effectiveness of combining teriparatide with antiresorptive therapy in postmenop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Antiresorptive agents (antiresorptive agents)
• Forteo (teriparatide)

Snippet

Sponsor: Medical University of Vienna | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED